GlassScriptPhysician profile
Nashaat Morgan
NPI 1699742932
$720.75
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $29.88 · 2022: $14.05 · 2023: $60.82 · 2024: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222 · Education: $14.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $222.14 |
| Education | $14.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $175.62 | 2019-2020 | |
| Amgen INC. | $149.84 | 2019-2024 | Enbrel, Tavneos, Otezla |
| Novartis Pharmaceuticals Corporation | $48.19 | 2019 | |
| Ani Pharmaceuticals, INC. | $47.68 | 2024 | Purified Cortrophin Gel |
| Janssen Biotech, INC. | $32.48 | 2023-2024 | Tremfya |
| Hikma Pharmaceuticals USA | $28.03 | 2019 | |
| Sebela Pharmaceuticals INC. | $28.03 | 2019 | |
| Ucb, INC. | $26.35 | 2019 | |
| Radius Health, INC. | $24.50 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.74 | 2024 | Saphnelo |
| Genzyme Corporation | $17.59 | 2019 | |
| Organon LLC | $15.97 | 2024 | |
| Celltrion USA INC. | $14.95 | 2023 | Yuflyma |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.05 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.90 | 2024 | Zoryve |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $13.88 | 2019 | |
| Sobi, INC | $13.49 | 2019 | |
| Abbvie INC. | $12.90 | 2019 | |
| Lilly USA, LLC | $12.85 | 2019 | |
| Antares Pharma, INC. | $12.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nashaat Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.